These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The emerging specialty pharmaceutical market segment. Giaquinta D Manag Care Interface; 2003 Apr; 16(4):35-6. PubMed ID: 12747139 [No Abstract] [Full Text] [Related]
6. Should cost-effectiveness take the blame? McGregor M CMAJ; 2003 Jun; 168(12):1528; author reply 1528-9. PubMed ID: 12796326 [No Abstract] [Full Text] [Related]
7. Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures? Gafni A; Birch S CMAJ; 2003 Apr; 168(7):849-51. PubMed ID: 12668543 [No Abstract] [Full Text] [Related]
8. Opportunities and challenges of specialty pharmaceuticals. Navarro RP; Johnson KA J Manag Care Pharm; 2013; 19(1):70-1. PubMed ID: 23383702 [No Abstract] [Full Text] [Related]
19. PBMs could manage Medicare drug benefit but need flexibility, guidelines. Landis NT Am J Health Syst Pharm; 2000 Apr; 57(8):729. PubMed ID: 10786254 [No Abstract] [Full Text] [Related]
20. I why we need a PDL and how it works. Hauser H Tex Med; 2004 Apr; 100(4):7. PubMed ID: 15303483 [No Abstract] [Full Text] [Related] [Next] [New Search]